All News

Amid fears of large coverage losses, New Hampshire is delaying its Medicaid work requirements; California has become the first state to offer Medicaid to young undocumented immigrants; physicians have delivered a healthy baby from the transplanted uterus of a deceased donor for the first time in the United States.

Pediatric patients with relapsed or refractory B acute lymphoblastic leukemia (B-ALL) with minimal residual disease (MRD) who were treated with blinatumomab proceeded to hematopoietic cell transplant (HCT) without delay and had limited side effects.

A recent study used Mendelian randomization, which uses genetic variants to randomly allocate individuals to groups based on genotype, to further investigate the causal relationship between body mass index (BMI) and psoriasis. It found that as BMI rises, so too does the risk for developing psoriasis.

In 2018, 33% of accountable care organizations (ACOs) assumed downside risk, up from 28% in 2012.

US District Court Judge Amit P. Mehta has ruled that HHS does not have the authority to require drug manufacturers to list the prices of their drugs in television ads.

The Trump administration is expected to unveil a series of initiatives on Wednesday, including new payment models to overhaul kidney disease care; a report from the inspector general of HHS found widespread hospice deficiencies; the number of undocumented immigrant children in California’s Medicaid program is slowly declining even as the state prepares to expand coverage to undocumented young adults.

Poor interpretation of imaging is the top reason for oncology malpractice lawsuits.

As President Trump spoke about the environment and the economy, the American Lung Association and the American Public Health Association said that they will sue the administration over its decision to repeal the Clean Power Plan, which was passed under the Obama administration to reduce carbon pollution from power plants.

Combining CRISPR with long-acting slow-effective release antiretroviral therapy—a recently developed therapeutic strategy—the researchers were able to effectively eliminate replication-competent HIV DNA from the genomes of approximately 30% of infected humanized mice.

The 5th Circuit Court of Appeals in New Orleans will hear arguments Tuesday in a lawsuit backed by the Trump administration seeking to reverse the Affordable Care Act (ACA); legislators return from a holiday break to try and reach an agreement on healthcare cost issues; a growing number of Americans in rural areas are turning to telehealth appointments amid hospital closings and a shortage of local primary care doctors, specialists, and other providers.

A new study by Willis Towers Watson finds technology plays an increasingly important role in employee health benefits.

Comorbidities are common for patients with asthma and chronic obstructive pulmonary disease (COPD) overlap.

Changes to Medigap as part of the Medicare Access and CHIP Reauthorization Act go into action beginning next year.

A new study by Mayo Clinic Researchers calls into question the current standard of care for treating smoldering multiple myeloma.

A study comparing the efficacy of burosumab with conventional treatment—oral phosphate and active vitamin D—found that burosumab, which blocks FGF23, was significantly more effective in alleviating symptoms.

As social determinants of health are being more intensely researched, one determinant that is already well understood and has a number of interventions in place and being studied is housing. Here are 5 things about housing in healthcare.

Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.

Some generic drugs may actually cost Medicare Part D beneficiaries more out-of-pocket than brand-name drugs because brand-name manufacturers can offer discounts that generic drug makers cannot pay.

The Triple Aim will be within reach when there is greater stakeholder engagement and systemic ownership. A good start is for more employers to provide more American workers with access to high-quality wellness programs that can impact chronic disease with population health strategies.

This week, we recap the top managed care news from the first half of 2019, including outcomes from some of the biggest diabetes trials, research into the annual Medicare wellness visit, and an experimental treatment in Parkinson disease.

A recent study examined the association between patients with secondary myelofibrosis (SMF) and later development of nonhematological second primary malignancies (SPM).

Researchers from the the University of Alabama finds the SIRT1 protein plays a key role in preventing chronic myeloid leukemia stem cell elimination.

Early detection and treatment of lung cancer through screening with low-dose computed tomography (CT) has been investigated as a potential tool for reducing lung cancer deaths, the leading cause of cancer death worldwide, for more than 2 decades. Published this week was an extended follow up study to the 2011 randomized National Lung Screening Trial that found a similar number of patients must be screened to prevent cancer deaths as determined in the original analysis.

Individuals in traditional blue-collar jobs were the main beneficiaries of the Affordable Care Act because they were less likely to have employer-based coverage before the law, according to a new study.

How can perioperative mobile apps can increase patient compliance while saving money?

In a session held during the Florida Society of Clinical Oncology’s annual meeting in April, panelist James Almas, MD, vice president and national medical director of clinical effectiveness at LabCorp, and previously a medical officer at CMS in the Coverage Analysis Group, announced that he expected the National Coverage Determination to be reopened for Foundation Medicine’s FDA-approved companion diagnostic. By the end of the month, CMS revealed that they had done just that.

Compared with patients who did not receive the deep-brain stimulation surgery, patients who received the surgery experienced improvements in urinary frequency, urgency, and inconsistence.

A federal appeals court rejected a request to delay next week's hearing on the constitutionality of the Affordable Care Act (ACA); Senator Elizabeth Warren, D-Massachusetts, is calling on former FDA Commissioner Scott Gottlieb, MD, to immediately resign from Pfizer's board of directors; Maine is joining a handful of other states in expanding access to abortion.